Literature DB >> 12435414

Effects of genetic depletion of monoamines on somatosensory cortical development.

C Alvarez1, T Vitalis, E A Fon, N Hanoun, M Hamon, I Seif, R Edwards, P Gaspar, O Cases.   

Abstract

Raised levels of serotonin cause alterations in the development of the barrelfield of the primary somatosensory cortex (S1) in rodents. We examined the development of S1 in genetic mouse models in which the levels of serotonin and/or dopamine and noradrenaline are drastically reduced. Mice lacking the vesicular monoamine transporter type 2 (VMAT2 KO) are hypomorphic with rare pups surviving until postnatal day (P) 6. Serotonin, dopamine and noradrenaline are almost undetectable in the brain. In S1 we find that the segregation of thalamocortical axons into whisker patterns is delayed by 1 day and that layer IV granular neurons fail to form normal barrels. Moreover, the growth of cortical layers II-IV is reduced. Despite severe malnutrition, we show that these alterations are not caused by increased cell death in the thalamus or S1. Moreover, the maturation of cortical neurons is not altered as reflected by calcium-binding protein immunolabeling. Mice lacking both VMAT2 and monoamine oxidase type A (MAOA) were generated. VMAT2-MAOA DKO mice are hypomorphic but survive until P13. Increased levels of serotonin but profoundly reduced dopamine and noradrenaline levels are found in the brains. In S1, alterations are similar to those observed in MAOA KO mice: thalamocortical axons and granular neurons failed to form barrels. In addition there is a severe reduction in the thickness of the upper cortical layers as in the VMAT2 KO mice. These results show that monoamines have no instructive effect per se on the formation of thalamocortical patterning in S1. However, monoamines appear to be essential for the normal cytoarchitectonic maturation of the granular (IV) and supragranular cortical layers (II-III). Since developmental cell death and chemoarchitectonic differentiation of these neurons are not modified, it is possible that these alterations result from migration defects and/or from altered synaptic maturation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435414     DOI: 10.1016/s0306-4522(02)00484-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.

Authors:  Nicolas Narboux-Nême; Corinne Sagné; Stephane Doly; Silvina L Diaz; Cédric B P Martin; Gaelle Angenard; Marie-Pascale Martres; Bruno Giros; Michel Hamon; Laurence Lanfumey; Patricia Gaspar; Raymond Mongeau
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

2.  Novel neuropathologic findings in the Haddad syndrome.

Authors:  Nestor D Tomycz; Robin L Haynes; Edith F Schmidt; Kate Ackerson; Hannah C Kinney
Journal:  Acta Neuropathol       Date:  2009-10-21       Impact factor: 17.088

3.  Pb exposure prolongs the time period for postnatal transient uptake of 5-HT by murine LSO neurons.

Authors:  Sunyoung Park; Andrew B C Nevin; Fernando Cardozo-Pelaez; Diana I Lurie
Journal:  Neurotoxicology       Date:  2016-10-19       Impact factor: 4.294

4.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET.

Authors:  Fernando Caravaggio; Jun Ku Chung; Eric Plitman; Isabelle Boileau; Philip Gerretsen; Julia Kim; Yusuke Iwata; Raihaan Patel; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2017-07-28       Impact factor: 5.038

Review 5.  Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development.

Authors:  Esmee S B van Kleef; Patricia Gaspar; Alexandre Bonnin
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

Review 6.  Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-03-14       Impact factor: 3.575

Review 7.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Postnatal growth defects in mice with constitutive depletion of central serotonin.

Authors:  Nicolas Narboux-Nême; Gaelle Angenard; Valentina Mosienko; Friederike Klempin; Pothitos M Pitychoutis; Evan Deneris; Michael Bader; Bruno Giros; Natalia Alenina; Patricia Gaspar
Journal:  ACS Chem Neurosci       Date:  2012-12-15       Impact factor: 4.418

Review 9.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

10.  Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Authors:  Neil D Woodward; David H Zald; Zhaohua Ding; Patrizia Riccardi; M Sib Ansari; Ronald M Baldwin; Ronald L Cowan; Rui Li; Robert M Kessler
Journal:  Neuroimage       Date:  2009-02-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.